INSIGHTS ON QUALITY CONTROL
-
Right-Sized Compliance: What Must Be True At Go-Live (And What Can Wait)
Validated go-live is a claim of control that must be defended under audit. Ten controls separate true compliance gates from operational improvements, and governance gaps pose the greater inspection risk.
-
Minimizing Drug Product Loss In Manufacturing
Explore how optimized analytical testing, reduced material wastage, and advanced sterile fill-finish technologies can work together to preserve valuable GMP material without compromising quality.
-
Monitoring Microbial Contamination Of Mammalian Cell Cultures
Mammalian cells are widely used to produce complex processed molecules. Explore a system that effectively detects microbial contamination in mammalian cell cultures and utilizes a newly formulated lysis buffer.
-
Practical Considerations For Aseptic Gowning In Contamination Control Strategies (CCS)
Personnel remain the most significant contributor to contamination risk. Explore these practical considerations for your CCS to address complex interactions between operators and their environment
-
How To Prepare For Risk-based Biological Reactivity Testing10/16/2026
Biological reactivity testing is moving from material classification toward risk-based evaluation, where chemistry data, exposure, and application determine what evidence is enough for each material.
-
Esco IntelliGlove Tester (EIGT)2/19/2026
Ensure sterility with wireless glove leak testing. Align with Annex 1 and ISO standards through portable, traceable, and cable-free integrity checks that optimize cleanroom safety and workflows.
-
Lessons From FDA 483s And Warning Letters: Cleanroom Compliance12/8/2025
Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.
-
Why Pharmaceutical Scientists Trust The Discovery Core Rheometer5/1/2026
Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.
-
Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres12/30/2024
Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.
QUALITY CONTROL SOLUTIONS
-
Mikart’s small-scale non-GMP lab accelerates development by enabling rapid testing and iteration at a lower cost.
-
Explore chromatography methods for sample preparation, residual solvent, and impurity analysis, critical steps for Active Pharmaceutical Ingredient (API) quality control.
-
PTI Inspection Systems are scientific instruments being deployed for high risk packaging applications. The environments in which these systems operate is often highly regulated with test results having a significant impact on operational decisions. The reliability and sensitivity of a CCI test method is critical to assure that correct decisions are made to maintain product quality and patient safety. If PTI’s equipment is going to test your packaging, we aim to deliver the most effective solution. Feasibility studies offer a detailed glimpse into the technological capabilities ahead of critical purchasing decisions. Feasibility studies can also act as a preliminary test method for an application. The results from feasibility or method development testing can be rolled out to the production environment for rapid validation and deployment.
-
The Aseptic Filling Isolator is a custom-designed cGMP Class A/ISO 5 isolator system specifically designed for batch scale pharmaceutical production of injectable products for pre-clinical and clinical trial studies.
-
Unlock higher yields and ensure regulatory success with a tailored process optimization program designed to eliminate contamination risks and stabilize biopharmaceutical workflows.